IL22RA1 and breast cancer: Highly metastatic breast cancer cells expressed elevated protein levels of pERK and pSTAT3 compared to low metastatic breast cancer cells and IL-22R1 silencing led to reduced protein levels of pERK and pSTAT3 upon IL-22 exposure (Figure S3).